Clinical Trials Browser

Phase 2 × INDUSTRY × burosumab × Clear all

NCT02304367 2024-05-06

Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)

Phase 2 Completed

17 enrolled 66 charts

Oncogenic osteomalacia, Nevus, Sebaceous of Jadassohn

NCT02722798 2022-09-06

A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome

Phase 2 Completed

Oncogenic osteomalacia, Nevus, Sebaceous of Jadassohn